Literature DB >> 15083881

Long-term results of multiple synovectomy for patients with refractory rheumatoid arthritis. Effects on disease activity and radiological progression.

H Nakamura1, H Tanaka, S Yoshino.   

Abstract

OBJECTIVES: We developed a radical multiple synovectomy (RaMS) procedure designed to reduce disease activity in refractory RA patients involving the excision of all inflamed synovial tissues. In this study we examined the long-term outcome of RaMS in terms of disease activity and articular destruction.
METHODS: Forty-two patients with refractory RA underwent RaMS and were followed up for an average of 7.3 years. Clinical findings and radiological outcome were evaluated and compared to a control group.
RESULTS: More than 40% of patients continued to maintain improvement up to 4 years after the operation. The number of swollen joints and painful joints, the erythrocyte sedimentation rate, CRP and rheumatoid factor quickly decreased after the operation. The beneficial effects continued for 4 years compared to patients treated with combination disease modifying anti-rheumatic drug therapy. The damage score worsened less rapidly in patients undergoing RaMS than in the control group. Articular destruction was less marked in the PIP, MP, wrist and ankle joints of patients who responded well to RaMS.
CONCLUSIONS: RaMS was effective for refractory RA in the short term and seemed to offer some advantages over other therapies in terms of slowing articular destruction. However, RaMS did not radically alter the natural disease course of RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083881

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Analysis of clinical factors related to the efficacy of shoulder arthroscopic synovectomy plus capsular release in patients with rheumatoid arthritis.

Authors:  Katsuaki Kanbe; Junji Chiba; Yasuo Inoue; Masashi Taguchi; Akiko Iwamatsu
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-12-24

2.  Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.

Authors:  Myew-Ling Toh; Gaelle Gonzales; Marije I Koenders; Anne Tournadre; David Boyle; Erik Lubberts; Yuan Zhou; Gary S Firestein; Wim B van den Berg; Pierre Miossec
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

3.  The rheumatoid forefoot.

Authors:  Francis Brooks; Kartik Hariharan
Journal:  Curr Rev Musculoskelet Med       Date:  2013-12

4.  Total ankle prostheses in rheumatoid arthropathy: Outcome in 52 patients followed for 1-9 years.

Authors:  Huub J L van der Heide; Bernard Schutte; Jan Willem K Louwerens; Frank H J van den Hoogen; Maarten C de Waal Malefijt
Journal:  Acta Orthop       Date:  2009-08       Impact factor: 3.717

Review 5.  Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?

Authors:  Fons A J van de Loo; Ruben L Smeets; Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2004-07-29       Impact factor: 5.156

6.  IL-17A and TNF-α Increase the Expression of the Antiapoptotic Adhesion Molecule Amigo-2 in Arthritis Synoviocytes.

Authors:  Giulia Benedetti; Paola Bonaventura; Fabien Lavocat; Pierre Miossec
Journal:  Front Immunol       Date:  2016-06-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.